Tags

Type your tag names separated by a space and hit enter

Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac.
Lancet Infect Dis. 2021 08; 21(8):1071-1072.LI

Authors+Show Affiliations

Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu 210008, China; Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu 210008, China.Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu 210008, China.Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu 210008, China; Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu 210008, China.Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu 210008, China; Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu 210008, China.Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu 210008, China; Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu 210008, China. Electronic address: dr.wu@nju.edu.cn.

Pub Type(s)

Letter
Observational Study
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

34051887

Citation

Chen, Yuxin, et al. "Serum Neutralising Activity Against SARS-CoV-2 Variants Elicited By CoronaVac." The Lancet. Infectious Diseases, vol. 21, no. 8, 2021, pp. 1071-1072.
Chen Y, Shen H, Huang R, et al. Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac. Lancet Infect Dis. 2021;21(8):1071-1072.
Chen, Y., Shen, H., Huang, R., Tong, X., & Wu, C. (2021). Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac. The Lancet. Infectious Diseases, 21(8), 1071-1072. https://doi.org/10.1016/S1473-3099(21)00287-5
Chen Y, et al. Serum Neutralising Activity Against SARS-CoV-2 Variants Elicited By CoronaVac. Lancet Infect Dis. 2021;21(8):1071-1072. PubMed PMID: 34051887.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac. AU - Chen,Yuxin, AU - Shen,Han, AU - Huang,Rui, AU - Tong,Xin, AU - Wu,Chao, Y1 - 2021/05/27/ PY - 2021/04/20/received PY - 2021/05/07/revised PY - 2021/05/07/accepted PY - 2021/5/31/pubmed PY - 2021/8/18/medline PY - 2021/5/30/entrez SP - 1071 EP - 1072 JF - The Lancet. Infectious diseases JO - Lancet Infect Dis VL - 21 IS - 8 SN - 1474-4457 UR - https://www.unboundmedicine.com/medline/citation/34051887/Serum_neutralising_activity_against_SARS_CoV_2_variants_elicited_by_CoronaVac_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1473-3099(21)00287-5 DB - PRIME DP - Unbound Medicine ER -